MedicarePartD.guide

A non-government resource built from CMS public data

emtricitabine-tenofovir on Blue MedicareRx Premier (S2893-003)

generic Truvada

Covered.

Tier 4 (non-preferred drug). No quantity limit.

35%
Patient pays / month
35%
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200/300 mg Tablet, Film Coated at a preferred retail pharmacy. Other covered strengths are listed below.

All 4 covered strengths and forms
FormTierPatient pays / monthLimits
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200/300 mg Tablet, Film Coated435%None
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 100/150 mg Tablet, Film Coated435%None
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 133/200 mg Tablet, Film Coated533%None
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 167/250 mg Tablet, Film Coated435%None

Other HIV drugs on this plan

Verify with the plan before prescribing or filling. Member services: (888)543-4917. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s2893-003